stoxline Quote Chart Rank Option Currency Glossary
  
ProKidney Corp. (PROK)
0.75  0.029 (3.96%)    05-12 16:00
Open: 0.7648
High: 0.7938
Volume: 604,729
  
Pre. Close: 0.7214
Low: 0.71
Market Cap: 220(M)
Technical analysis
2025-05-12 4:51:10 PM
Short term     
Mid term     
Targets 6-month :  1.05 1-year :  1.37
Resists First :  0.9 Second :  1.17
Pivot price 0.83
Supports First :  0.46 Second :  0.38
MAs MA(5) :  0.7 MA(20) :  0.81
MA(100) :  1.23 MA(250) :  1.88
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  22.2 D(3) :  15.6
RSI RSI(14): 45
52-week High :  4.44 Low :  0.46
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ PROK ] has closed above bottom band by 33.9%. Bollinger Bands are 22% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.79 - 0.8 0.8 - 0.8
Low: 0.7 - 0.71 0.71 - 0.71
Close: 0.74 - 0.75 0.75 - 0.76
Company Description

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Headline News

Mon, 12 May 2025
PROKIDNEY CORP. SEC 10-Q Report - TradingView

Mon, 12 May 2025
ProKidney Reports First Quarter 2025 Financial Results and Business Highlights - Stock Titan

Tue, 08 Apr 2025
PROK stock touches 52-week low at $0.49 amid market challenges - Investing.com

Mon, 07 Apr 2025
Institutional owners may take dramatic actions as ProKidney Corp.'s (NASDAQ:PROK) recent 32% drop adds to one-year losses - simplywall.st

Thu, 27 Mar 2025
Here's Why We're Watching ProKidney's (NASDAQ:PROK) Cash Burn Situation - Yahoo Finance

Tue, 18 Mar 2025
ProKidney Corp (PROK) Reports $163.3 Million Net Loss for 2024, - GuruFocus

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 0 (M)
Shares Float 130 (M)
Held by Insiders 7.816e+007 (%)
Held by Institutions 30 (%)
Shares Short 11,930 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -1.7292e+008
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -67 %
Return on Assets (ttm) 856.5 %
Return on Equity (ttm) -25.9 %
Qtrly Rev. Growth 76000 %
Gross Profit (p.s.) 0
Sales Per Share -26.08
EBITDA (p.s.) 48101.3
Qtrly Earnings Growth -0.7 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -126 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.03
Price to Cash Flow -0.16
Stock Dividends
Dividend 0
Forward Dividend 1.564e+007
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android